tag:blogger.com,1999:blog-8550428.post111149929686804065..comments2024-03-28T13:38:36.788-04:00Comments on Pharma Marketing Blog: DTC Straight TalkVladhttp://www.blogger.com/profile/04114063498108633047noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-8550428.post-1111684940026423252005-03-24T12:22:00.000-05:002005-03-24T12:22:00.000-05:00CEO Bill Weldon's comments and J&J's more balanced...CEO Bill Weldon's comments and J&J's more balanced approach with Alchemy to DTC are timely and correct. Drugs are much more complex and risky than typical consumer products, despite many manufacturer's early DTC experience. As a result, I suspect we will see a concurrent growth in direct response advertising, which permits more indepth and comparative information to be shared with prospective or existing patients.<BR/><BR/>The times they are a-changing!<BR/><BR/>Neil<BR/>Neil H. Gray<BR/>Managing Partner<BR/>Healthcare Trends & Strategies, LLC<BR/>3 Coventry Square<BR/>Bridgewater, New Jersey 08807-1338<BR/>(908) 722-1843 office<BR/>(413) 618-4078 eFAX<BR/>9088830018@mobile.att.net text messages<BR/>graysters@aol.com emailAnonymousnoreply@blogger.com